1593 related articles for article (PubMed ID: 7641363)
21. Angiotensin II formation by an alternative pathway during exercise in humans.
Miura S; Ideishi M; Sakai T; Motoyama M; Kinoshita A; Sasaguri M; Tanaka H; Shindo M; Arakawa K
J Hypertens; 1994 Oct; 12(10):1177-81. PubMed ID: 7836734
[TBL] [Abstract][Full Text] [Related]
22. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.
Campbell DJ; Kladis A; Valentijn AJ
J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048
[TBL] [Abstract][Full Text] [Related]
23. Role of the tissue renin-angiotensin system in the action of angiotensin-converting enzyme inhibitors.
Tokita Y; Oda H; Franco-Saenz R; Mulrow PJ
Proc Soc Exp Biol Med; 1995 Apr; 208(4):391-6. PubMed ID: 7700888
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
Inglessis N; Nussberger J; Hagmann M; Hiesse-Provost O; Insuasty J; Reid J; Ménard J; Brunner HR
J Cardiovasc Pharmacol; 1995 Jun; 25(6):986-93. PubMed ID: 7564346
[TBL] [Abstract][Full Text] [Related]
25. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
[TBL] [Abstract][Full Text] [Related]
26. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
[TBL] [Abstract][Full Text] [Related]
27. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
[TBL] [Abstract][Full Text] [Related]
28. Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans.
Fisher ND; Allan D; Kifor I; Gaboury CL; Williams GH; Moore TJ; Hollenberg NK
Hypertension; 1994 Jan; 23(1):44-51. PubMed ID: 8282330
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP
J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
[TBL] [Abstract][Full Text] [Related]
30. Salt-sensitive hypertension resulting from nitric oxide synthase inhibition is associated with loss of regulation of angiotensin II in the rat.
Hodge G; Ye VZ; Duggan KA
Exp Physiol; 2002 Jan; 87(1):1-8. PubMed ID: 11805851
[TBL] [Abstract][Full Text] [Related]
31. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
32. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.
Mooser V; Nussberger J; Juillerat L; Burnier M; Waeber B; Bidiville J; Pauly N; Brunner HR
J Cardiovasc Pharmacol; 1990 Feb; 15(2):276-82. PubMed ID: 1689424
[TBL] [Abstract][Full Text] [Related]
33. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
34. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients.
Millar JA; McGrath BP; Matthews PG; Johnston CI
Clin Sci (Lond); 1981 Jul; 61(1):75-83. PubMed ID: 7018813
[TBL] [Abstract][Full Text] [Related]
35. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
36. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
Russo D; Minutolo R; Pisani A; Esposito R; Signoriello G; Andreucci M; Balletta MM
Am J Kidney Dis; 2001 Jul; 38(1):18-25. PubMed ID: 11431176
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan.
Azizi M; Chatellier G; Guyene TT; Ménard J
J Hypertens; 1999 Apr; 17(4):561-8. PubMed ID: 10404959
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure.
Arnold AC; Okamoto LE; Gamboa A; Shibao C; Raj SR; Robertson D; Biaggioni I
Hypertension; 2013 Mar; 61(3):701-6. PubMed ID: 23266540
[TBL] [Abstract][Full Text] [Related]
39. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
[TBL] [Abstract][Full Text] [Related]
40. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
